Benznidazole
- Generic Name
- Benznidazole
- Drug Type
- Small Molecule
- Chemical Formula
- C12H12N4O3
- CAS Number
- 22994-85-0
- Unique Ingredient Identifier
- YC42NRJ1ZD
Overview
Benznidazole was granted accelerated approval for the treatment of Chagas disease in children 2-12 years of age by the FDA on August 29, 2017. It is the first treatment made available in the United States for Chagas disease.
Background
Benznidazole was granted accelerated approval for the treatment of Chagas disease in children 2-12 years of age by the FDA on August 29, 2017. It is the first treatment made available in the United States for Chagas disease.
Indication
For use in the treatment of Chagas disease in children 2-12 years of age .
Associated Conditions
- Chagas' Disease caused by Typanosoma cruzi
Clinical Trials
FDA Approved Products
Benznidazole
Manufacturer:Exeltis USA, Inc.
Route:ORAL
Strength:100 mg in 1 1
Approved: 2023/11/10
NDC:0642-7464
Benznidazole
Manufacturer:Exeltis USA, Inc.
Route:ORAL
Strength:12.5 mg in 1 1
Approved: 2023/11/10
NDC:0642-7463
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath